CoronaVac (SARS-CoV-2 inactivated vaccine) has been largely used as the main immunogen for COVID-19 in several countries; however, its immunogenicity, antibody decay and booster dose response in ...

The Editors would like to publicly acknowledge the people listed below who served as reviewers on the journal during 2024. Without their efforts, the quality of the journal could not be sustained.

The Lupus Foundation of America is a charitable organization with tax-exempt status granted under Section 501(c)(3) of the Internal Revenue Code. The LFA’s Federal ID# is 43-1131436. Donations are tax ...

Background: Cardiovascular disease (CVD) is a leading cause of morbidity and mortality in systemic lupus erythematosus (SLE). 1 Patients with SLE have a 2- to 10-fold higher risk of ischemic heart ...

You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your ...

TitleAuthorDate Evaluation of the effects of pre-exposure treatment with hydroxychloroquine on the risk of COVID-19 infection and on the efficacy of anti-COVID-19 vaccination during lupus or ...

Background Neuropsychiatric symptoms are highly prevalent among systemic lupus erythematosus (SLE) patients, being clinically observed in up to 80% of adult and 95% of pediatric patients. Type 1 ...

Background Mycophenolate mofetil (MMF) is commonly used to treat SLE, but many patients experience gastrointestinal (GI) side effects, which are responsible for drug discontinuation in up to 30 ...

How can I track my submitted paper? You can find the status of your manuscript by entering your Manuscript ID on Where Is My Paper? It will also be visible in your Author Dashboard on the manuscript ...

Sign up here to receive an email when new content is published in the journal. If you are already signed up, you can manage your preferences on MyAccount.